A 2-part trial shows a new antibody that suppresses HIV when combined with antiretroviral therapy (ART).
Gina Kokosky, Assistant Editor
Advertisement
Articles by Gina Kokosky, Assistant Editor
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
Accelerated Approval of Cancer Drugs: Benefit or Burden?
3
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
4
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
5
